Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria Transmission
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and impact of ivermectin, administered
as single or repeated dose, in combination with artemether-lumefantrine in reducing the
proportion of mosquitoes that survive and become infected after feeding on a blood meal from
a malaria-infected individual.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborators:
Centre national de recherche et de formation sur le paludisme Radboud University
Treatments:
Artemether Artemether-lumefantrine combination Artemether, Lumefantrine Drug Combination Artemisinins Ivermectin Lumefantrine